Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02210676
Other study ID # 2014P001041
Secondary ID
Status Withdrawn
Phase N/A
First received August 5, 2014
Last updated December 20, 2016
Start date June 2014

Study information

Verified date December 2016
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Aim:

The purpose of the study is to learn more about how a person recovers after treatment for mallet finger injury. The investigators want to identify the best outcome after mallet finger injury and how to improve treatment strategies.

Primary null hypothesis:

There are no statistically significant factors associated with extensor lag between 4 weeks and 4 months after immobilization is discontinued for a mallet finger among demographic, injury, and treatment factors.

Secondary null hypothesis:

There are no statistically significant factors associated with PROMIS upper extremity function between 4 weeks and 4 months after completion of immobilization for a mallet finger among demographic, psychological, injury, and treatment factors.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age and older

- English fluency and literacy

- Mallet finger fracture or non-fracture

- Mallet finger subluxation or non-subluxation

Exclusion Criteria:

- Pregnant Women

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms

  • Patients Present With Mallet Finger

Intervention

Other:
PROMIS Upper Extremity

Likert Pain Scale

Mallet Finger Extensor Lag Measurement


Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mallet Finger Extensor Lag Baseline No
Primary Mallet Finger Extensor Lag 4 weeks to 4 months after diagnosis No
Secondary Patient Reported Outcomes Measure Information System (PROMIS) Upper Extremity A computerized assessment of upper extremity function 4 weeks to 4 months after diagnosis No
Secondary Likert Pain Scale 4 weeks to 4 months after diagnosis No
Secondary Demographics Questionnaire 4 weeks to 4 months after diagnosis No